Cargando…

Molecular Characteristics and Quantitative Proteomic Analysis of Klebsiella pneumoniae Strains with Carbapenem and Colistin Resistance

Carbapenem-resistant Klebsiella pneumoniae (CRKP) are usually multidrug resistant (MDR) and cause serious therapeutic problems. Colistin is a critical last-resort therapeutic option for MDR bacterial infections. However, increasing colistin use has led to the emergence of extensively drug-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hao, Ling, Yang, Xiao, Chen, Huiling, Mo, Zexun, Li, Yujun, Wei, Shuquan, Zhao, Ziwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598126/ https://www.ncbi.nlm.nih.gov/pubmed/36289999 http://dx.doi.org/10.3390/antibiotics11101341

Ejemplares similares

Multicenter Study of Colistin Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae Strains in China
por: Weng, Yuesong, et al.
Publicado: (2023)

Resistome of carbapenem- and colistin-resistant Klebsiella pneumoniae clinical isolates
por: Lomonaco, Sara, et al.
Publicado: (2018)

Analysis of colistin resistance in carbapenem-resistant Enterobacterales and XDR Klebsiella pneumoniae
por: Bir, Raunak, et al.
Publicado: (2022)

Evaluation of the Organotellurium Compound AS101 for Treating Colistin- and Carbapenem-Resistant Klebsiella pneumoniae
por: Yang, Tsung-Ying, et al.
Publicado: (2021)

Combination of Colistin and Azidothymidine Demonstrates Synergistic Activity against Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae
por: Chang, Ya-Ting, et al.
Publicado: (2020)

Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
por: Huang, Po-Han, et al.
Publicado: (2022)

In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains
por: Erdem, Fatma, et al.
Publicado: (2020)

The threat of colistin resistance among carbapenem-resistant Klebsiella pneumoniae isolates in Iran
por: Haeili, Mehri, et al.
Publicado: (2018)

Investigation of double-carbapenem efficiency in experimental sepsis of colistin-resistant Klebsiella pneumoniae
por: Kosar, Imran, et al.
Publicado: (2021)

Heteroresistance Is Associated With in vitro Regrowth During Colistin Treatment in Carbapenem-Resistant Klebsiella pneumoniae
por: Wang, Yifan, et al.
Publicado: (2022)

Emergence of Colistin Resistance in Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae Under the Pressure of Tigecycline
por: Zhang, Yawei, et al.
Publicado: (2021)

Risk Factors for Colistin-Resistant Carbapenem-Resistant Klebsiella pneumoniae in the Postacute Care Setting
por: Zhang, Helen L, et al.
Publicado: (2022)

Resistance to Colistin in Klebsiella Pneumoniae: A 4.0 Strain?
por: Granata, Guido, et al.
Publicado: (2017)

Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant Klebsiella pneumoniae in vitro
por: Yu, Lan, et al.
Publicado: (2019)

Prolonged Outbreak of Carbapenem and Colistin-Resistant Klebsiella pneumoniae at a Large Tertiary Hospital in Brazil
por: Rocha, Verônica França Diniz, et al.
Publicado: (2022)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)

Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
por: Zhang, Feiyang, et al.
Publicado: (2021)

Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2020)

In vivo Emergence of Colistin and Tigecycline Resistance in Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae During Antibiotics Treatment
por: Chen, Jiawei, et al.
Publicado: (2021)

Phenotypic Changes Associated With In Vivo Evolution of Colistin Resistance in ST11 Carbapenem-Resistant Klebsiella pneumoniae
por: Xie, Miaomiao, et al.
Publicado: (2022)

In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Mantzana, Paraskevi, et al.
Publicado: (2023)

Molecular Mechanisms of Colistin Resistance in Klebsiella pneumoniae in a Tertiary Care Teaching Hospital
por: Liu, Yanling, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Escherichia coli
por: Jitaree, Kamonchanok, et al.
Publicado: (2019)

Epidemiological characteristics and molecular evolution mechanisms of carbapenem-resistant hypervirulent Klebsiella pneumoniae
por: Han, Yu-Ling, et al.
Publicado: (2022)

A Retrospective Whole-Genome Sequencing Analysis of Carbapenem and Colistin-Resistant Klebsiella pneumoniae Nosocomial Strains Isolated during an MDR Surveillance Program
por: Gentile, Bernardina, et al.
Publicado: (2020)

Outbreak of KPC-2 Carbapenem-resistant Klebsiella pneumoniae ST76 and Carbapenem-resistant K2 Hypervirulent Klebsiella pneumoniae ST375 strains in Northeast China: molecular and virulent characteristics
por: Su, Shanshan, et al.
Publicado: (2020)

Evolution of tigecycline- and colistin-resistant CRKP (carbapenem-resistant Klebsiella pneumoniae) in vivo and its persistence in the GI tract
por: Zhang, Rong, et al.
Publicado: (2018)

Molecular epidemiological characteristics of carbapenem-resistant Klebsiella pneumoniae among children in China
por: Jin, Zhengjiang, et al.
Publicado: (2022)

Drug Resistance Genes and Molecular Epidemiological Characteristics of Carbapenem-Resistant Klebsiella pneumonia
por: Liao, Yiqun, et al.
Publicado: (2023)

In vivo Emergence of Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae Mediated by Premature Termination of the mgrB Gene Regulator
por: Kong, Yingying, et al.
Publicado: (2021)

High prevalence of mgrB-mediated colistin resistance among carbapenem-resistant Klebsiella pneumoniae is associated with biofilm formation, and can be overcome by colistin-EDTA combination therapy
por: Shein, Aye Mya Sithu, et al.
Publicado: (2022)

Genomic Epidemiology of Carbapenem- and Colistin-Resistant Klebsiella pneumoniae Isolates From Serbia: Predominance of ST101 Strains Carrying a Novel OXA-48 Plasmid
por: Palmieri, Mattia, et al.
Publicado: (2020)

The Occurence of Colistin-Resistant Hypervirulent Klebsiella pneumoniae in China
por: Lu, Yang, et al.
Publicado: (2018)

Prevalence of the colistin resistance gene MCR-1 in colistin-resistant Klebsiella pneumoniae in Egypt
por: Abozahra, Rania, et al.
Publicado: (2023)

The lncRNA HOTAIR regulates autophagy and affects lipopolysaccharide‐induced acute lung injury through the miR‐17‐5p/ATG2/ATG7/ATG16 axis
por: Li, Yujun, et al.
Publicado: (2021)

Carbapenem-Resistant Klebsiella pneumoniae Exhibiting Clinically Undetected Colistin Heteroresistance Leads to Treatment Failure in a Murine Model of Infection
por: Band, Victor I., et al.
Publicado: (2018)

Emergence of Colistin and Carbapenem Resistance in Extended-Spectrum β-Lactamase Producing Klebsiella pneumoniae Isolated from Chickens and Humans in Egypt
por: Elmonir, Walid, et al.
Publicado: (2021)

Successful management of colistin- and carbapenem-resistant Klebsiella pneumoniae-associated ecthyma gangrenosum in acute myeloid leukemia: A rare complication
por: Jamal, Aisha, et al.
Publicado: (2022)

Epidemiology and mortality outcome of carbapenem- and colistin-resistant Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa bloodstream infections
por: Balkhair, A., et al.
Publicado: (2023)

Infection with Carbapenem-resistant Hypervirulent Klebsiella Pneumoniae: clinical, virulence and molecular epidemiological characteristics
por: Li, Linlin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gmke803p5d4dnfvmdbljrdia0r